Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: Programmatic Grants in Food and Health - LOI

McMaster University

$0.00

Program Grant in Peanut Allergy Basic and Translational Research

FY 2012-13

Summary
Food allergy is an important health problem. There has been an alarming increase in the prevalence of food allergy over the last 15 years. The diagnosis of food allergy is extremely distressing for patients, primarily children, and their families. Furthermore, food allergy has far-reaching societal impact, ranging from manufacturing practices and food labeling regulations to dietary habits and school guidelines. It is of grave concern that even the most knowledgeable food allergic individuals may experience an astonishingly high rate of accidental exposures, particularly to peanut and other nuts. We have chosen to focus on peanut allergy for two reasons. First, it is the food allergy most associated with anaphylaxis, an acute and potentially lethal allergic reaction. Second, unlike other food allergies, peanut allergy generally starts in early childhood and is life-long in at least 80% of peanut allergic patients. A unique aspect of food allergy is that, unlike other allergic diseases, there are currently no available treatments with the exception of epinephrine that is given after the start of an acute allergic reaction. Our view is that lack of therapeutic options is a direct reflection of lack of knowledge in fundamental aspects of peanut allergy. Here, we have outlined three lines of investigation that could dramatically impact our ability to prevent, treat and reverse disease: 1) elucidating the mechanisms underlying the development of peanut allergy, 2) uncovering the molecular basis of anaphylactic reactions, and 3) understanding the basis of peanut allergy persistence. We take the stance that transformative research requires a multi-disciplinary team incorporating internationally recognized expertise and state-of-the-art technology spanning from experimental research to clinical translation and management. Findings from this team effort will impact dietary habits and nutritional practices resulting in enhanced health and reduced risk of chronic disease.
Program
Operating Grant: Programmatic Grants in Food and Health - LOI
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
262613
Name
Jordana Manel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Operating Grant: Programmatic Grants in Food and Health - LOI
Projecttitle
Program Grant in Peanut Allergy Basic and Translational Research
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$0
Cihrequipment2
$0
Programname2
Operating Grant: Programmatic Grants in Food and Health - LOI
Keyworddelim
Anaphylaxis; B Cells; Food Allergy; Germ Free Mice; Immunoglobulins; Immunology; Metabolomics; Metagenomics; Mice; Peanut
Abstract
Food allergy is an important health problem. There has been an alarming increase in the prevalence of food allergy over the last 15 years. The diagnosis of food allergy is extremely distressing for patients, primarily children, and their families. Furthermore, food allergy has far-reaching societal impact, ranging from manufacturing practices and food labeling regulations to dietary habits and school guidelines. It is of grave concern that even the most knowledgeable food allergic individuals may experience an astonishingly high rate of accidental exposures, particularly to peanut and other nuts. We have chosen to focus on peanut allergy for two reasons. First, it is the food allergy most associated with anaphylaxis, an acute and potentially lethal allergic reaction. Second, unlike other food allergies, peanut allergy generally starts in early childhood and is life-long in at least 80% of peanut allergic patients. A unique aspect of food allergy is that, unlike other allergic diseases, there are currently no available treatments with the exception of epinephrine that is given after the start of an acute allergic reaction. Our view is that lack of therapeutic options is a direct reflection of lack of knowledge in fundamental aspects of peanut allergy. Here, we have outlined three lines of investigation that could dramatically impact our ability to prevent, treat and reverse disease: 1) elucidating the mechanisms underlying the development of peanut allergy, 2) uncovering the molecular basis of anaphylactic reactions, and 3) understanding the basis of peanut allergy persistence. We take the stance that transformative research requires a multi-disciplinary team incorporating internationally recognized expertise and state-of-the-art technology spanning from experimental research to clinical translation and management. Findings from this team effort will impact dietary habits and nutritional practices resulting in enhanced health and reduced risk of chronic disease.
Competitiondate
201205
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jordana, Manel
Approvedterm
1 an 0 mois